M. Gillespie

Donor-derived Cell-free DNA Combined With Histology Improves Prediction of Estimated Glomerular Filtration Rate Over Time in Kidney Transplant Recipients Compared With Histology Alone

M. Haas, S. Jordan, J. Mirocha, 2020, Transplantation direct.

Clazakizumab for desensitization in highly sensitized patients awaiting transplantation

M. Haas, S. Jordan, Xiaohai Zhang, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Donor-derived Cell-free DNA May Confirm Real-time Response to Treatment of Acute Rejection in Renal Transplant Recipients.

M. Gillespie, Randall Hinojosa, K. Chaffin, 2019, Transplantation.

Evaluation of Clazakizumab (Anti–Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts

M. Haas, S. Jordan, Xiaohai Zhang, 2022, Kidney international reports.

Results of ‘two-in-one’ single-stage revision total knee arthroplasty for infection with associated bone loss

I. Brenkel, P. Walmsley, M. Gillespie, 2022, Bone & joint open.

Collaborative practice agreement in solid organ transplantation

S. Bartlett, A. Haririan, B. Ravichandran, 2018, International Journal of Clinical Pharmacy.

Collaborative Overview of coronaVIrus impact on ORTHopaedic training in the UK (COVI - ORTH UK)

J. M. Lynch, G. Matheron, E. Dickenson, 2021, The Surgeon.

An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function

M. Haas, S. Jordan, A. Vo, 2022, Transplantation.